By entering this website, you confirm that you are at least 21 years of age and that you are a qualified researcher or purchasing on behalf of a research institution.
All products sold by BioNex are for laboratory research purposes only. They are not intended for human or animal consumption, and no medical, therapeutic, or diagnostic use is expressed or implied.
You acknowledge that BioNex assumes no liability for misuse, misapplication, or unauthorized use of any product purchased from this website.
By clicking “I Agree,” you accept full responsibility for compliance with all applicable laws and regulations.
Your access is restricted because of your age.
$65.00
Advanced Study of Non-Incretin Metabolic Signaling.
Cagrilintide 10mg is a long-acting amylin analog studied for appetite suppression and weight loss. Ideal for research into metabolic regulation and obesity, this peptide from Bionex Peptides acts as a potent agonist of the amylin receptors. Unlike GLP-1 analogs that primarily target the hypothalamus, Cagrilintide is investigated for its unique interaction with the area postrema and the nucleus tractus solitarius in the hindbrain to modulate energy intake.
Peptide Name: Cagrilintide
Concentration: 10mg per vial
Purity: 99%+ HPLC & MS Verified
Mechanism: Long-acting Amylin Receptor Agonist
Format: Lyophilized Professional Grade Powder
Storage: Store at -20°C for maximum stability and bio-activity.
Hindbrain Satiety Regulation: Researchers utilize Cagrilintide 10mg to study the mechanisms of non-incretin-mediated satiety, focusing on how amylin analogs influence caloric intake through hindbrain signaling.
Gastric Emptying Modulation: Studies focus on the peptide’s role in slowing gastric motility, providing insights into the regulation of postprandial glucose levels and nutrient absorption rates.
Synergistic Incretin Interaction: Cagrilintide is a primary focus for research involving co-administration with GLP-1 analogs, investigating how dual-pathway activation (Amylin + GLP-1) affects metabolic homeostasis.
Glucagon Suppression Studies: Emerging laboratory research analyzes the role of amylin agonism in inhibiting inappropriate glucagon secretion, particularly in the context of glucose-dependent insulinotropic models.
America’s Premier Source: We provide only the highest-grade research materials, ensuring that your laboratory protocols are supported by absolute purity and consistency.
HPLC Verified Quality: Every vial of Cagrilintide 10mg undergoes rigorous batch testing to guarantee a 99%+ purity profile with zero cross-contamination.
Rapid & Discreet Logistics: We prioritize your research timelines with fast, secure, and temperature-controlled shipping across the United States.